Blogs about: Fda Wall Street Journal Online Schering Plough Nda Anda Complaints Execessive Regulation Safety Side Effects June 30 2008
Featured Blog
It is usually unwise to complain about the FDA, for the record, in your company's name, in the Wall Street Journal
. . . . but, in the case of Schering-Plough, and CEO Fred Hassan — that rule doesn’t really apply, inasmuch as Schering has so very little good-will left to lose with the FDA. Mr. Hassan c… more →
It is usually unwise to complain about the FDA, for the record, in your company's name, in the Wall Street Journal
condor wrote 1 year ago: . . . . but, in the case of Schering-Plough, and CEO Fred Hassan — that rule doesn’t rea … more →
